Article ID Journal Published Year Pages File Type
5705094 Ophthalmology 2017 8 Pages PDF
Abstract
Intravitreous melphalan is an effective treatment for vitreous seeding in retinoblastoma, resulting in high rates of ocular survival and disease-free survival. However, in this study, each injection of melphalan was associated, on average, with a decrement in ERG response. The findings suggest increased toxicity (1) when OAC is given within 1 week of the intravitreous injection and (2) in more deeply pigmented eyes.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , ,